Urological Oncology: Prostate Cancer

No authors listed

Comment

No authors listed. J Urol. 2022 Jan.

. 2022 Jan;207(1):229-231.

doi: 10.1097/JU.0000000000002285. Epub 2021 Oct 18.

No abstract available

Comment on

Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer.
Plym A, Penney KL, Kalia S, Kraft P, Conti DV, Haiman C, Mucci LA, Kibel AS. Plym A, et al. J Natl Cancer Inst. 2022 May 9;114(5):771-774. doi: 10.1093/jnci/djab058. J Natl Cancer Inst. 2022. PMID: 33792693 Free PMC article.
MRI-Targeted or Standard Biopsy in Prostate Cancer Screening.
Eklund M, Jäderling F, Discacciati A, Bergman M, Annerstedt M, Aly M, Glaessgen A, Carlsson S, Grönberg H, Nordström T; STHLM3 consortium. Eklund M, et al. N Engl J Med. 2021 Sep 2;385(10):908-920. doi: 10.1056/NEJMoa2100852. Epub 2021 Jul 9. N Engl J Med. 2021. PMID: 34237810 Clinical Trial.
Temporal association of prostate cancer incidence with World Trade Center rescue/recovery work.
Goldfarb DG, Zeig-Owens R, Kristjansson D, Li J, Brackbill RM, Farfel MR, Cone JE, Yung J, Kahn AR, Qiao B, Schymura MJ, Webber MP, Dasaro CR, Shapiro M, Todd AC, Prezant DJ, Boffetta P, Hall CB. Goldfarb DG, et al. Occup Environ Med. 2021 Oct;78(10):699-706. doi: 10.1136/oemed-2021-107405. Epub 2021 Sep 10. Occup Environ Med. 2021. PMID: 34507966 Free PMC article.